Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01632319 · ClinicalTrials.gov registry record · NA
Therapy for Undergraduate College Students Who Binge Drink and Are Depressed
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 96
- Enrollment target
NCT01632319: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01632319 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 96 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01632319, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the effectiveness of 2 different therapy courses for undergraduate college students who binge drink and experience depressive symptoms.
Primary Outcome
A measure assessing how much one drinks in a typical week
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy
- BEHAVIORAL Combined Motivational Interviewing and Cognitive Behavioral Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2012-05 |
| Est. Completion | 2016-11 |
| Phase | NA |
What the finished NCT01632319 record still lists
NCT01632319 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Cognitive Behavioral Therapy is the first listed.
NCT01632319 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01632319 about?
NCT01632319 is a clinical study titled "Therapy for Undergraduate College Students Who Binge Drink and Are Depressed". The purpose of this study is to investigate the effectiveness of 2 different therapy courses for undergraduate college students who binge drink and experience depressive symptoms.
What is the current status of trial NCT01632319?
This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2012-05. Estimated completion is 2016-11.
What interventions are being tested in trial NCT01632319?
The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL), Combined Motivational Interviewing and Cognitive Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01632319?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01632319's enrollment target sits among peer trials
96 925th of 2000 higher than 1,070 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia